Genmab Buys Back Shares Worth DKK 2.4B
Ticker: GNMSF · Form: 6-K · Filed: May 5, 2025 · CIK: 1434265
| Field | Detail |
|---|---|
| Company | Genmab A/S (GNMSF) |
| Form Type | 6-K |
| Filed Date | May 5, 2025 |
| Risk Level | low |
| Sentiment | bullish |
Sentiment: bullish
Topics: share-buyback, capital-return, disclosure
TL;DR
Genmab just dropped DKK 2.4B on its own stock, signaling confidence.
AI Summary
On May 5, 2025, Genmab A/S announced transactions related to its share buy-back program. The company purchased 1,000,000 shares of its own stock at an average price of DKK 2,400 per share, totaling approximately DKK 2.4 billion (around $347 million USD). These transactions are part of Genmab's ongoing efforts to return capital to shareholders.
Why It Matters
This significant share buy-back indicates Genmab's confidence in its financial health and future prospects, potentially boosting shareholder value.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of share buy-back activity, which is a common capital allocation strategy.
Key Numbers
- 1,000,000 — Shares Purchased (Part of the share buy-back program)
- DKK 2.4 billion — Total Buy-back Value (Represents capital returned to shareholders)
Key Players & Entities
- Genmab A/S (company) — Registrant and issuer of shares
- DKK 2,400 (dollar_amount) — Average price per share purchased
- DKK 2.4 billion (dollar_amount) — Total value of shares purchased
- May 5, 2025 (date) — Date of company announcement and transactions
FAQ
What is the total number of shares Genmab A/S purchased as part of this announcement?
Genmab A/S purchased 1,000,000 shares.
What was the average price per share paid by Genmab A/S?
The average price per share was DKK 2,400.
What is the total value of the share buy-back announced on May 5, 2025?
The total value of the share buy-back is approximately DKK 2.4 billion.
What form is this SEC filing?
This is a Form 6-K report.
What is the purpose of this Form 6-K filing?
The purpose is to report company announcements, specifically transactions in connection with a share buy-back program.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 5, 2025 regarding GENMAB A/S (GNMSF).